SCHEMBL6765347

SCHEMBL6765347

CCOc1cccc(-c2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNPH1 O43598 10/20 0.59
DPP4 P27487 1/20 0.55
MEN1 O00255 1/20 0.55
SLC28A1 O00337 1/20 0.55
MAP3K7 O43318 1/20 0.55
SLC28A2 O43868 1/20 0.55
GAPDH P04406 1/20 0.55
ADORA3 P0DMS8 1/20 0.55
MAPK1 P28482 1/20 0.55
ADORA2A P29274 1/20 0.55
ADORA2B P29275 1/20 0.55
ADORA1 P30542 1/20 0.55
STAT6 P42226 1/20 0.55
PI4KA P42356 1/20 0.55
KMT2A Q03164 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
PI4K2B Q8TCG2 1/20 0.55
DOT1L Q8TEK3 1/20 0.55
SLC29A1 Q99808 1/20 0.55
PI4K2A Q9BTU6 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6761689 0.92 DNPH1 (0.66) DNPH1ADORA3ADORA2AADORA1SLC29A1
SCHEMBL6760523 0.86 DNPH1 (0.73) DNPH1ADORA3MAPK1STAT6SMN1; SMN2
SCHEMBL6765355 0.85 SLC29A1 (0.66) DNPH1DPP4MEN1SLC28A1MAP3K7
SCHEMBL7030062 0.85 SLC29A1 (0.58) DNPH1ADORA3ADORA2AADORA1STAT6
SCHEMBL6760682 0.84 ADK (0.63) DNPH1DPP4MEN1SLC28A1MAP3K7
SCHEMBL6423141 0.84 DNPH1 (0.71) DNPH1DPP4MEN1SLC28A1MAP3K7
SCHEMBL6758946 0.84 DNPH1 (0.71) DNPH1DPP4MEN1SLC28A1MAP3K7
SCHEMBL6761653 0.83 DNPH1 (0.74) DNPH1DPP4MEN1SLC28A1MAP3K7
SCHEMBL6760662 0.82 DNPH1 (0.69) DNPH1DPP4ADORA3MAPK1STAT6
SCHEMBL6763303 0.82 SLC29A1 (0.68) DNPH1DPP4MEN1SLC28A1MAP3K7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110718-A1 Anti-HCV nucleoside derivatives DEVOS RENE (GB) 2004-06-10 US claimed
CN-1466591-A Nucleoside derivatives - 2004-01-07 CN claimed
US-20030008841-A1 Anti-HCV nucleoside derivatives F. HOFFMAN-LA ROCHE, A SWISS COMPANY (CH) 2003-01-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030008841-A1 Anti-HCV nucleoside derivatives PNP, HAVCR2, NUDT14 DNPH1 1216/4885DPP4 124/4885MEN1 4883/4885
US-20040110718-A1 Anti-HCV nucleoside derivatives PNP, HAVCR2, NUDT14 DNPH1 1216/4885DPP4 124/4885MEN1 4883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.